Atom | Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)

Due Dates: May 7, 2025 (AIDS) | September 7, 2025 (AIDS) | January 7, 2026 (AIDS) | May 7, 2026 (AIDS)

Funding Amounts: No budget limit; project period up to 5 years; budgets must reflect actual project needs.

Summary: Supports epidemiological and observational research on long-term cardiopulmonary sequelae after tuberculosis (TB) treatment in adults and children, with or without HIV infection.

Key Information: Applications requesting ≥$500,000 in direct costs in any year must contact NIH at least 6 weeks before submission.

Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)

Sign in to see full grant listing